Table 2.
Summary of Diagnosis Patterns. This table includes six outcomes: follow-up time in weeks, visits per month, individuals with at least one new diagnosis in the “post-COVID-19 period,” individuals with at least one new PCC-related diagnosis in the “post-COVID-19 period,” the number of new diagnoses per month in the “post-COVID-19 period,” and the number of new PCC-related diagnoses per month in the “post-COVID-19 period.” Each outcome is stratified by both COVID-19 severity, “pre-“/”post-COVID-19 period,” and vaccination status. Statistics are presented as median (IQR) for continuous variables and n (%) for categorical variables, and sample sizes for cohorts are provided.
|
Overall (n = 44,198)a |
Fully Vaccinated (n = 16,468)a |
Unvaccinated (n = 25,736)a, b |
|||||
|---|---|---|---|---|---|---|---|
| Outcome | Cohort | Pre-COVID-19 | Post-COVID-19 | Pre-COVID-19 | Post-COVID-19 | Pre-COVID-19 | Post-COVID-19 |
| Follow-up Time (Weeks) | Overall (n = 44,198) | 90.86 (59.04, 99.71) | 25.14 (13.29, 41) | 94.29 (67.43, 100.29) | 17.71 (7.43, 25.29) | 88 (54.29, 99.14) | 34.71 (19.29, 44.86) |
| Mild/Moderate (n = 41,629) | 90.43 (58.86, 99.57) | 25 (13.29, 40.57) | 94.07 (67.29, 100.29) | 17.57 (7.43, 25.14) | 87.29 (53.86, 98.86) | 34.57 (19.29, 44.71) | |
| Severe (n = 2,569) | 96.43 (66.86, 101) | 29.71 (14.14, 45.29) | 98.07 (70.82, 101.29) | 19.14 (6.82, 27.57) | 95.71 (64.71, 100.86) | 38.14 (19.29, 46.43) | |
| Hospitalized, No ICU (n = 1,900) | 96.14 (66.68, 101) | 29.36 (15.71, 45) | 97.86 (69.04, 101.14) | 20.29 (7.71, 27.57) | 95.29 (64.71, 100.86) | 38.14 (20.29, 46.29) | |
| Hospitalized and ICU (n = 588) | 97.71 (70.32, 101.14) | 35.71 (15.11, 46.43) | 98.71 (81.79, 101.29) | 18.86 (6.43, 30.21) | 97.43 (68.29, 101.14) | 41.57 (21.43, 47) | |
| Deceased (n = 136) | 96.64 (64.64, 101.43) | 2.29 (0.86, 4.46) | 99.64 (69.96, 101.82) | 1.79 (0.75, 3.11) | 96.43 (60.89, 101.07) | 2.43 (0.86, 5.57) | |
| Visits Per Month | Overall (n = 44,198) | 0.64 (0.25, 1.44) | 0.54 (0.18, 1.26) | 0.93 (0.42, 1.91) | 0.45 (0.18, 0.99) | 0.51 (0.21, 1.15) | 0.54 (0.18, 1.35) |
| Mild/Moderate (n = 41,629) | 0.59 (0.25, 1.36) | 0.45 (0.18, 1.17) | 0.89 (0.38, 1.83) | 0.45 (0.18, 0.99) | 0.47 (0.17, 1.06) | 0.54 (0.18, 1.26) | |
| Severe (n = 2,569) | 1.44 (0.59, 3.06) | 1.44 (0.54, 3.25) | 2.17 (0.98, 3.95) | 1.35 (0.45, 2.64) | 1.27 (0.51, 2.55) | 1.53 (0.54, 3.43) | |
| Hospitalized, No ICU (n = 1,900) | 1.44 (0.59, 2.93) | 1.26 (0.45, 2.8) | 2.08 (0.98, 3.66) | 1.13 (0.45, 2.37) | 1.23 (0.51, 2.42) | 1.35 (0.45, 2.89) | |
| Hospitalized and ICU (n = 588) | 1.61 (0.64, 3.65) | 2.75 (0.99, 5.33) | 2.85 (0.91, 5.10) | 2.53 (0.9, 4.69) | 1.4 (0.55, 3.23) | 2.89 (0.99, 5.6) | |
| Deceased (n = 136) | 1.36 (0.51, 3.53) | 1.9 (0.95, 4.99) | 2.61 (1.2, 3.95) | 2.85 (0.95, 12.83) | 1.13 (0.47, 3.45) | 0.95 (0.95, 4.51) | |
| 1 + New Diagnosisc | Overall (n = 44,198) | 34,257 (79 %) | 11,917 (75 %) | 20,809 (82 %) | |||
| Mild/Moderate (n = 41,629) | 31,950 (79 %) | 11,324 (74 %) | 19,222 (82 %) | ||||
| Severe (n = 2,569) | 2,307 (90 %) | 593 (87 %) | 1,587 (91 %) | ||||
| Hospitalized, No ICU (n = 1,900) | 1,682 (89 %) | 454 (86 %) | 1,127 (90 %) | ||||
| Hospitalized and ICU (n = 588) | 567 (97 %) | 126 (97 %) | 421 (97 %) | ||||
| Deceased (n = 136) | 101 (76 %) | 24 (73 %) | 70 (76 %) | ||||
| 1 + New PCC-Related Diagnosisc | Overall (n = 44,198) | 16,205 (59 %) | 5,469 (51 %) | 9,930 (64 %) | |||
| Mild/Moderate (n = 41,629) | 14,784 (58 %) | 5,128 (51 %) | 8,930 (63 %) | ||||
| Severe (n = 2,569) | 1,421 (71 %) | 341 (63 %) | 1,000 (74 %) | ||||
| Hospitalized, No ICU (n = 1,900) | 1,005 (68 %) | 251 (59 %) | 692 (71 %) | ||||
| Hospitalized and ICU (n = 588) | 403 (80 %) | 86 (77 %) | 303 (81 %) | ||||
| Deceased (n = 136) | 29 (49 %) | 9 (43 %) | 16 (48 %) | ||||
| New Diagnoses Per Month | Overall (n = 44,198) | 0.36 (0.09, 0.90) | 0.27 (0, 0.72) | 0.36 (0.09, 0.90) | |||
| Mild/Moderate (n = 41,629) | 0.27 (0.09, 0.81) | 0.27 (0, 0.72) | 0.36 (0.09, 0.90) | ||||
| Severe (n = 2,569) | 0.99 (0.27, 2.26) | 0.9 (0.27, 2.08) | 1.08 (0.36, 2.44) | ||||
| Hospitalized, No ICU (n = 1,900) | 0.81 (0.27, 1.90) | 0.63 (0.18, 1.62) | 0.9 (0.27, 1.90) | ||||
| Hospitalized and ICU (n = 588) | 2.17 (0.90, 4.06) | 2.17 (0.90, 3.81) | 2.17 (0.95, 4.15) | ||||
| Deceased (n = 136) | 1.9 (0.95, 13.31) | 6.65 (0, 19.01) | 0.95 (0.95, 10.69) | ||||
| New PCC-Related Diagnoses Per Month | Overall (n = 44,198) | 0.09 (0, 0.18) | 0.09 (0, 0.18) | 0.09 (0, 0.18) | |||
| Mild/Moderate (n = 41,629) | 0.09 (0, 0.18) | 0.09 (0, 0.18) | 0.09 (0, 0.18) | ||||
| Severe (n = 2,569) | 0.09 (0, 0.27) | 0.09 (0, 0.18) | 0.09 (0, 0.27) | ||||
| Hospitalized, No ICU (n = 1,900) | 0.09 (0, 0.27) | 0.09 (0, 0.18) | 0.09 (0, 0.27) | ||||
| Hospitalized and ICU (n = 588) | 0.18 (0.09, 0.36) | 0.18 (0.09, 0.36) | 0.18 (0.09, 0.36) | ||||
| Deceased (n = 136) | 0 (0, 1.90) | 0 (0, 1.90) | 0 (0, 0.95) | ||||
a
Median (IQR) or Frequency (%).
b
Includes those with unknown vaccination status.
c
In the ∼ 11 month-long “post-COVID-19 period”.